Question 1

What is the Global Gene Therapy Market size?

Accepted Answer

The Global Gene Therapy Market size was worth USD 7.12 Billion in 2024.

Question 2

What is the projected Global Gene Therapy Market growth under the study period?

Accepted Answer

For the years 2025-2033, the Global Gene Therapy Market growth is expected to be around 19.45%.

Question 3

Which region holds the highest Global Gene Therapy Market Share?

Accepted Answer

The Global Gene Therapy Market is currently dominated North America.

Question 4

What is the global Gene Therapy market segmentation covered in the report?

Accepted Answer

The global Gene Therapy market is segmented By Indication (Large B-Cell Lymphoma, Multiple Myeloma, Spinal Muscular Atrophy (SMA), Acute Lymphoblastic Leukemia (ALL), Melanoma (lesions), Inherited Retinal Disease, Beta-Thalassemia Major/SCD, Others), By Vector Type (Lentivirus, RetroVirus & gamma RetroVirus, AAV, Modified Herpes Simplex Virus, Adenovirus, Others), By Route of Administration (Intravenous, Others).

Question 5

Who are the leading global Gene Therapy market manufacturers/players profiled in the report?

Accepted Answer

The leading players in the global Gene Therapy market are Amgen Inc., Novartis AG, F. Hoffmann-La Roche, Gilead Sciences Inc., Bluebird Bio Inc., Bristol-Myers Squibb Company, Legend Biotech, BioMarin, UniQure N.V., Merck & Co., Sarepta Therapeutics Inc.